A detailed history of Jacobs Levy Equity Management, Inc transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 388,748 shares of IKNA stock, worth $594,784. This represents 0.0% of its overall portfolio holdings.

Number of Shares
388,748
Previous 424,377 8.4%
Holding current value
$594,784
Previous $700,000 4.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.6 - $1.85 $57,006 - $65,913
-35,629 Reduced 8.4%
388,748 $672,000
Q2 2024

Aug 14, 2024

SELL
$1.24 - $1.82 $110,438 - $162,094
-89,063 Reduced 17.35%
424,377 $700,000
Q1 2024

May 15, 2024

BUY
$1.27 - $2.0 $580,701 - $914,490
457,245 Added 813.68%
513,440 $729,000
Q4 2023

Feb 14, 2024

SELL
$1.33 - $4.4 $1,397 - $4,624
-1,051 Reduced 1.84%
56,195 $110,000
Q3 2023

Nov 16, 2023

BUY
$4.09 - $6.43 $120,352 - $189,209
29,426 Added 105.77%
57,246 $247,000
Q2 2023

Aug 14, 2023

BUY
$3.5 - $7.31 $33,866 - $70,731
9,676 Added 53.33%
27,820 $182,000
Q1 2023

May 15, 2023

BUY
$2.62 - $4.97 $47,537 - $90,175
18,144 New
18,144 $62,000
Q2 2022

Aug 15, 2022

BUY
$3.23 - $7.4 $132,155 - $302,771
40,915 New
40,915 $181,000

Others Institutions Holding IKNA

About Ikena Oncology, Inc.


  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $55.5M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.